Search Results - "Atassi N"

Theme 09 - Clinical Trials and Trial Design.

Authors: Katz, J. Vu, T. Chiò, A. et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2023 Suppl1, Vol. 24, p209-229. 21p.

Theme 9 Clinical Trials and Trial Design.

Authors: Ghandour, S. Avan, A. Benedetti, A. et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024 Suppl 1, Vol. 25, p232-261. 30p.

Psychophysiological effects of low-frequency sound mediated by room size, room shape, and stimulus duration.

Authors: Oomen P Geffen R Gentile D et al.

Source: Frontiers in cognition [Front Cognit] 2026 May 20; Vol. 5, pp. 1806052. Date of Electronic Publication: 2026 May 20 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918663771906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2813-4532 (Electronic) Linking ISSN: 28134532 NLM ISO Abbreviation: Front Cognit Subsets: PubMed not MEDLINE

Remote Wireless Oral Control of a Robotic Manipulator and a Powered Wheelchair, and Its Evaluation with Paralyzed Users.

Authors: Pálsdóttir, Ásgerður Arna Kæseler, Rasmus Leck Bentsen, Bo et al.

Source: Applied Sciences (2076-3417); Jul2026, Vol. 16 Issue 13, p6609, 18p

Poster Author Index.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2018 Supplement, Vol. 19, p389-397. 9p.

Poster Author Index.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2017 Supplement, Vol. 18, p325-332. 8p.

The Molecular Basis of Partial Reversal or Significant Slowing of ALS, Parkinson's Disease, and Lewy Body Dementia by Mesenchymal Exosomes/Secretome.

Authors: Prodromos, Chadwick C. Del Villar, Ruby Striegel, Andrew et al.

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 10, p4483. 14p.

Longitudinal CSF and Serum Biomarker Dynamics in Tofersen-Treated SOD1 -ALS: A Real-World Multicentre Cohort Study.

Authors: Giordano, Andrea Mandrioli, Jessica Cerri, Federica et al.

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 10, p4208. 20p.

Natural history of the revised ALS functional rating scale and its association with survival: the PRECISION-ALS Extant Study.

Authors: van Eijk, Ruben P. A. Weemering, Daphne N. Opie-Martin, Sarah et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2025 Suppl 1, Vol. 26, p30-40. 11p.

Spanish adaptation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).

Authors: Mascías Cadavid, Javier Radakovic, Ratko Radakovic, Chelsea et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. May2025, Vol. 26 Issue 3/4, p375-378. 4p.

Author Index.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Nov2014 Supplement, Vol. 15, p212-218. 7p.

Author Index.

Source: Amyotrophic Lateral Sclerosis. Oct2012 Supplement, Vol. 13, p189-194. 6p.

Session Author Index.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2018 Supplement, Vol. 19, p85-87. 3p.

Selective Silencing of TDP-43 P. G376D Mutation Reverses Key Amyotrophic Lateral Sclerosis-Related Cellular Deficits.

Authors: Romano, Roberta Ruotolo, Giorgia Perrone, Francesco et al.

Source: Biomolecules (2218-273X). Mar2026, Vol. 16 Issue 3, p393. 17p.

Antisense Dipeptide Repeat Proteins Drive Widescale Purine Metabolism Aberration in C9orf72 Amyotrophic Lateral Sclerosis via ADA.

Authors: Hall, Benjamin Castelli, Lydia Higginbottom, Adrian et al.

Source: International Journal of Molecular Sciences. Feb2026, Vol. 27 Issue 4, p1953. 34p.

Minimum clinically important difference for drug effectiveness in an area of patient-oriented therapeutic goals in amyotrophic lateral sclerosis.

Authors: Chiò, Adriano Foucher, Juliette Gwathmey, Kelly G et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Aug2025, Vol. 26 Issue 5/6, p389-398. 10p.

Poster Author Index.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2019 Supplement, Vol. 20, p348-354. 7p.

Author Index.

Source: Amyotrophic Lateral Sclerosis. Oct2010, Vol. 11, p173-180. 8p.

Author Index.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Nov2015 Supplement, Vol. 16, p250-255. 6p.

Modulation of the miR-485-3p/PGC-1α Pathway by ASO-Loaded Nanoparticles Attenuates ALS Pathogenesis.

Authors: Ryu, In Soo Ha, Dae-In Jung, Yeon-Joo et al.

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 2, p615. 22p.